4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthonitrile, 98%, 250mg

Óxido de circonio (IV) + 3 % molar de Y2O3-nano polvo 99,9 % 250 g

2,3-Dimethyl-1 H -indole-5-carboxylic acid ethyl ester, 95.0%, 5g

5-Chlorothiophene-2-sulfonamide, 98.0%, 100g

4-tert-Butyl-4'-fluorobenzhydrol, 97.0%, 5g

3,3''-Difluoro-5'-(3-fluoro-4-formylphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbaldehyde, 97%, 1g

Pyrazolo[1,5-a]pyridin-2-ylmethanol, 96%, 1g

4,5-Dichloro-2-fluoroaniline, 95.0%, 1g

5'-(3-Formyl-4-hydroxyphenyl)-4,4''-dihydroxy-[1,1':3',1''-terphenyl]-3,3''-dicarbaldehyde, 98%, 250mg

1-(a-D-ribofuranosyl)uracil, 95.0%, 100mg

2-(bromomethyl)-4,5-dimethyl-1,3-thiazole hydrobromide, 95.0%, 5g

2-Fluoro-3-(hydroxymethyl)benzonitrile, 95.0%, 10g

2-(Cyclobutanecarboxamido)-2-methylpropanoic acid, 95.0%, 1g